We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > treatment-resistant

News List

FDA Approves Drug for Treatment-Resistant forms of TB americanpharmaceuticalreview
August 15, 2019
The U.S. Food and Drug Administration (FDA) approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs.
Phase III success for Janssen’s esketamine in treatment-resistant depression pharmatimes
June 21, 2018
Janssen has presented data from pivotal Phase III clinical studies backing use of esketamine spray in treatment-resistant depression.
Attacking treatment-resistant prostate cancer by blocking its stress response fiercebiotech
May 03, 2018
Prostate cancer cells rely on protein synthesis to fuel their growth, but there can be too much of a good thing: Prostate tumors that are flooded with protein will actually die.
Amorsa to collaborate with J&J on treatment-resistant depression therapy europeanpharmaceuticalreview
January 06, 2017
Amorsa Therapeutics has announced a research, option and license agreement with Janssen Pharmaceuticals to develop and commercialise a novel small molecule drug candidate for treatment-resistant depression based on Amorsa’s proprietary ketamine analog tec